Metabolic identification of carnitine biomarkers for the differential diagnosis of uterine disorders in bitches.
The study indicates that the uterine carnitine profile may help differentiate between uterine disorders in bitches, but further research is needed to validate these findings.
Where it sits
this study against the rest of the l-carnitine (levocarnitine) corpusSummary and findings
This study aimed to identify metabolic biomarkers for differentiating uterine disorders in bitches, specifically cystic endometrial hyperplasia (CEH)-mucometra, endometritis, and pyometra. Thirty-nine bitches aged 2-13 years were classified by uterine histology and underwent metabolomic analysis of 32 carnitines. The findings suggest variations in carnitine metabolism according to the underlying uterine disorder.
Abstract
Recent studies have improved the understanding of uterine disorders in bitches, but accurate differential diagnosis remains challenging, particularly between degenerative conditions, such as cystic endometrial hyperplasia (CEH)-mucometra, and inflammatory/infectious disorders, as endometritis and pyometra. Because clinical and imaging findings often lack histopathological precision, this study aimed to identify in situ metabolic biomarkers for more accurate differentiation among CEH-Mucometra, endometritis, and pyometra. Thirty-nine bitches aged 2-13 years underwent elective or therapeutic ovariohysterectomy and were classified by uterine histology into CEH-Mucometra (n = 10), Endometritis (n = 10), Pyometra (n = 10), and Control/Diestrus (n = 9) groups. Endometrial fragments were subjected to targeted metabolomic analysis of 32 carnitines using LC-MS/MS with a 3200 QTRAP spectrometer and MarkerView 1.2.1 software. Orthogonal contrasts evaluated uterine disorders, lesion type, and differences between endometritis and pyometra. Statistical comparisons included Diestrus vs. diseased groups, CEH-Mucometra vs. inflammatory groups, and Endometritis vs. Pyometra, at P < 0.05. Of the 32 carnitines analyzed, 15 were quantified in at least one group, while 17 were undetected. Propionylcarnitine was lower in Mucometra than in inflammatory groups. Free carnitine, acetylcarnitine, propionylcarnitine, and butyrylcarnitine differed between Endometritis and Pyometra. Pyometra showed higher acetylcarnitine, malonylcarnitine/3-hydroxy-butyrylcarnitine, methylmalonyl/3-hydroxy-isovalerylcarnitine, and hexanoylcarnitine compared with CEH-Mucometra and Diestrus. Endometritis showed higher malonylcarnitine/3-hydroxy-butyrylcarnitine and methylmalonyl/3-hydroxy-isovalerylcarnitine than Mucometra. Notably, glutarylcarnitine/3-hydroxy-hexanoylcarnitine and 3-hydroxy-octadecenoylcarnitine were identified exclusively in Pyometra. Despite the inherent methodological limitations, it was concluded that canine endometrial carnitine metabolism varies according to the underlying uterine disorder. Thus, the uterine carnitine profile is promising for differential diagnosis, including two specific carnitine types differentially detected in the pyometra group.
Background
This paper addresses the challenge of accurately diagnosing uterine disorders in bitches, particularly differentiating between degenerative and inflammatory conditions. Previous studies have highlighted the complexity of these diagnoses due to overlapping clinical and imaging findings. Identifying metabolic biomarkers could enhance diagnostic precision and improve clinical outcomes.
Methods
The study involved 39 bitches aged 2-13 years who underwent elective or therapeutic ovariohysterectomy. They were classified into four groups based on uterine histology: CEH-Mucometra (n=10), Endometritis (n=10), Pyometra (n=10), and Control/Diestrus (n=9). Targeted metabolomic analysis of 32 carnitines was performed using LC-MS/MS, and statistical comparisons were made at P<0.05.
Results
The primary endpoint revealed that 15 carnitines were quantified across the groups. Propionylcarnitine was significantly lower in the Mucometra group compared to inflammatory groups. Pyometra exhibited higher levels of acetylcarnitine compared to CEH-Mucometra and Diestrus, while Endometritis showed higher levels of malonylcarnitine/3-hydroxy-butyrylcarnitine than Mucometra.
Interpretation
These findings suggest that carnitine metabolism varies with the type of uterine disorder, aligning with previous literature that indicates metabolic alterations in disease states. While the statistical significance of the findings is noted, the clinical relevance may be limited by the small sample size and the need for further validation in larger cohorts. The study's methodological limitations may also confound the conclusions drawn.
Key findings
- 15 of 32 carnitines were quantified in at least one group.
- Propionylcarnitine was lower in Mucometra than in inflammatory groups.
- Pyometra showed higher acetylcarnitine compared with CEH-Mucometra and Diestrus.
- Endometritis showed higher malonylcarnitine/3-hydroxy-butyrylcarnitine than Mucometra.
- Glutarylcarnitine/3-hydroxy-hexanoylcarnitine was identified exclusively in Pyometra.
Limitations
- small sample size (n=39)
- methodological limitations in metabolic analysis
- potential confounding factors in histological classification
- no long-term follow-up to assess diagnostic utility